A Study of MK-2060 in Participants With Chronic and/or End-Stage Kidney Disease (MK-2060-011)

Clinical trial NCT05656040 · COMPLETED

Trial details

NCT number: NCT05656040
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

End-Stage Renal Disease End-Stage Kidney Disease Kidney Failure, Chronic

Start date: 2023-02-08
Primary completion: 2024-08-12
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.